Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talma Brenner

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Experimental Neurology|January 21, 2006
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoproteinMichal Irony-Tur-Sinai, Nikolaos Grigoriadis, Athanasios Lourbopoulos, et al.
Journal of Neuroimmunology|August 12, 2008
Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmineEran Nizri, Michal Irony-Tur-Sinai, Nabil Faranesh, et al.
Journal of the Neurological Sciences|December 14, 2002
A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammationMichal Irony-Tur-Sinai, Israel Vlodavsky, Shmuel A Ben-Sasson, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fractionSara Fuchs, Tali Feferman, Roberto Meidler, et al.
Journal of Neuroinflammation|October 15, 2013
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic interventionDevorah Gur-Wahnon, Tehila Mizrachi, Florence-Yehudith Maaravi-Pinto, et al.
Journal of Neuroinflammation|April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
Experimental Neurology|February 21, 2015
Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunizationErdem Tuzun, Sonia Berrih-Aknin, Talma Brenner, et al.
Journal of Neuroinflammation|March 19, 2013
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAILHodaya Prinz-Hadad, Tehila Mizrachi, Michal Irony-Tur-Sinai, et al.
Archives of Neurology|August 10, 2011
Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?Adi Vaknin-Dembinsky, Oded Abramsky, Panayiota Petrou, et al.
Journal of Immunology Research|June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle WeaknessTehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Experimental Neurology|January 21, 2006
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoproteinMichal Irony-Tur-Sinai, Nikolaos Grigoriadis, Athanasios Lourbopoulos, et al.
Journal of Neuroimmunology|August 12, 2008
Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmineEran Nizri, Michal Irony-Tur-Sinai, Nabil Faranesh, et al.
Journal of the Neurological Sciences|December 14, 2002
A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammationMichal Irony-Tur-Sinai, Israel Vlodavsky, Shmuel A Ben-Sasson, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fractionSara Fuchs, Tali Feferman, Roberto Meidler, et al.
Journal of Neuroinflammation|October 15, 2013
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic interventionDevorah Gur-Wahnon, Tehila Mizrachi, Florence-Yehudith Maaravi-Pinto, et al.
Journal of Neuroinflammation|April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
Experimental Neurology|February 21, 2015
Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunizationErdem Tuzun, Sonia Berrih-Aknin, Talma Brenner, et al.
Journal of Neuroinflammation|March 19, 2013
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAILHodaya Prinz-Hadad, Tehila Mizrachi, Michal Irony-Tur-Sinai, et al.
Archives of Neurology|August 10, 2011
Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?Adi Vaknin-Dembinsky, Oded Abramsky, Panayiota Petrou, et al.
Journal of Immunology Research|June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle WeaknessTehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Pageof 5